MGF

Compound Overview

Research Use Only. Not for Human Consumption.

MGF 2mg is supplied by Nexus as an unpegylated mechano growth factor peptide for controlled in-vitro research workflows. The provided chemistry record classifies MGF as an IGF-1Ec / mechano growth factor peptide and describes it as an unpegylated mechano growth factor E-peptide, commonly represented as a 24-amino-acid IGF-1 splice-variant-derived peptide.

The source record also makes an important identity distinction: this product is unpegylated MGF. It should not inherit PEG-MGF molecular-weight data or be treated as analytically interchangeable with PEG-MGF. PEG-MGF contains a polymer modification and is described in the source data as having variable mass, while this MGF record lists the unpegylated peptide formula and molecular weight shown below.

• Product: MGF
• SKU: FM2
• Available Research Size: 2mg
• Catalog Category: Growth Hormone Secretagogues
• Classification: IGF-1Ec / mechano growth factor peptide
• Sequence: YQPPSTNKNTKSQRRKGSTFEEHK
• Physical Form: Lyophilized powder
• Use: For in-vitro research use only. Not for human consumption.

Research Background & Published Literature

The provided research background identifies MGF as the unpegylated mechano growth factor peptide SKU and notes that vendor records typically define it as a short half-life unpegylated peptide. That background is included here only as research-context identity language. It is not a human-use claim, veterinary-use claim, dosing statement, therapeutic statement, or disease-related statement.

The supplied record does not include PubMed identifiers, paper titles, authors, journal names, experimental models, assay conditions, concentration ranges, biological outcome data, or citation-level summaries. Because those details are not present, this generated description does not add unsupported literature claims or infer mechanistic findings from adjacent compounds.

Two source references are included in the MGF research record for identity and general compound-profile context:

Researchers evaluating MGF should use these references and current lot-level documentation as starting points for compound identification, while keeping unpegylated MGF separate from PEG-MGF in inventory records, analytical review, and internal study design.

Researchers reviewing the literature around this compound can use the peer-reviewed resources below for additional context on mechanism of action, signaling pathways, and controlled laboratory research applications:

• Mills et al. (2007) — Exp Cell Res
• Kandalla et al. (2011) — Mech Ageing Dev
• Tang et al. (2017) — Mol Brain

Storage, Handling & Stability Guidelines

This dossier does not establish a storage temperature for this catalog presentation. Confirm storage and handling against the final lot label, the applicable Safety Data Sheet (SDS), and a laboratory-validated SOP.

Use the applicable lot/source record for storage of unopened material. Any diluent selection, preparation, temperature, aliquoting, or post-reconstitution hold conditions must be established by a qualified laboratory under a validated SOP; this page does not establish a stability window.

• Keep lyophilized MGF sealed, desiccated, and protected from light during storage.
• Confirm storage and handling against the final lot label, the applicable Safety Data Sheet (SDS), and a laboratory-validated SOP; this dossier does not establish a temperature.
• Use a validated laboratory SOP and the applicable lot/source record for any preparation or post-reconstitution handling.
• Maintain traceability between source vial, aliquot label, handling date, and operator records.
• Use appropriate personal protective equipment and institutional chemical-safety procedures for research peptides.

Quality Assurance & Lab Verification

The Certificate of Analysis for this catalog item is pending. No provisional batch, assay, method, analyst, or release data is published in this product dossier. Check the Lab Verified archive for documentation status.